Fig. 1: The impact of correlates of protection on vaccine clinical development.
From: A government-led effort to identify correlates of protection for COVID-19 vaccines
How timelines for vaccine development can be shortened with a known CoP. Yellow, small safety and immunogenicity trials; blue, large efficacy trials.
